NeuroSense Therapeutics Ltd. Deferred Tax Liabilities, Leasing Arrangements
NeuroSense Therapeutics Ltd. (NRSN) had Deferred Tax Liabilities, Leasing Arrangements of $39.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesLeasingArrangements · last filed 2026-03-31
- 2025-12-31: Deferred Tax Liabilities, Leasing Arrangements $39.00K.
- 2024-12-31: Deferred Tax Liabilities, Leasing Arrangements $19.00K.
- 2023-12-31: Deferred Tax Liabilities, Leasing Arrangements $35.00K.
| Period end | Deferred Tax Liabilities, Leasing Arrangements |
|---|---|
| 2025-12-31 | $39.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $19.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $35.00K 20-F · filed 2025-04-07 |